Angiotensin I ELISA kit

PRODUCT EXPLANATION: ACETYLCHOLINESTERASE MARKER IN ENZYME-IMMUNOASSAYS|Grassi J., Pradelles P. Compounds labelled by the acetylcholinesterase of Electrophorus Electricus. Its preparation process and its use as a tracer or marquer in enzymo-immunological determinations. United States patent, N° 1,047,330. September 10, 1991|Grassi J., Pradelles P. The use of Acetylcholinesterase as a Universal marker in Enzyme-Immunoassays. Proceedings of the Third International Meeting on Cholinesterases, American Chemical Society (1991)|Pradelles P., Grassi J., Maclouf J. Enzyme Immunoassays of Eicosanoids Using Acetylcholinesterase. Methods in Enzymology (1990), vol. 187, 24-34|PRODUCT EXPLANATION: ANGIOTENSIN I|Speth RC, Giese MJ , Update on the Renin-Angiotensin System. J Pharmacol Clin Toxicol 1(1): 1004 (2013)|Ghazi L, Drawz P., Advances in understanding the renin-angiotensin-aldosterone system (RAAS) in blood pressure control and recent pivotal trials of RAAS blockade in heart failure and diabetic nephropathy. F1000Res. 2017 Mar 21;6. pii: F1000 Faculty Rev-297|Vian J, Pereira C, Chavarria V et al, The renin-angiotensin system: a possible new target for depression. BMC Med. 2017 Aug 1;15(1):144|Pacurari, Kafoury R., Tchounwou P.B. and Ndebele K., The Renin-Angiotensin-Aldosterone System in Vascular Inflammation and Remodeling.International Journal of Inflammation, Volume 2014, Article ID 689360|Paulis L, Unger T. Novel therapeutic targets for hypertension. Nat Rev Cardiol. 2010 Aug;7(8):431-41|PRODUCT EXPLANATION: KIT DEVELOPMENT|Valentin MA, Ma S, Zhao A, Legay F, Avrameas A. Validation of immunoassay for protein biomarkers: Bioanalytical study plan implementation to support pre-clinical and clinical studies. J Pharm Biomed Anal. (2011) 55(5): 869-877|European Medicines Agency. Guideline on bioanalytical method validation, 21 July 2011